SEARCH
COVID-19 vaccines remain effective vs. Omicron XE variant, says an infectious diseases expert
PTVPhilippines
2022-04-05
Views
1
Description
Share / Embed
Download This Video
Report
COVID-19 vaccines remain effective vs. Omicron XE variant, says an infectious diseases expert
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x89q7dv" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
04:06
Infectious diseases expert, nagbabala na maaaring maging dominanteng variant ang XBB.1.5 Omicron Subvariant
00:43
Palasyo: COVID-19 vaccines ng bansa, nananatiling epektibo vs Omicron variant
02:26
Palasyo: Mababang bilang ng severe COVID-19 cases ngayon, dahil na rin sa COVID-19 vaccines; Mga ginagamit na bakuna, epektibo pa rin sa omicron variant
01:29
Proteksyon ng COVID-19 vaccines vs. serious symptoms, bumaba sa 85% dahil sa Omicron variant -27 patay sa sunog sa isang gusali sa Osaka, Japan; Anggulo ng arson, iniimbestigahan -11 indibidwal kabilang ang 2 dayuhan, patay sa flash flood sa Iraq
02:42
FDA, tiniyak na mabisa ang COVID-19 vaccines vs. bagong variants; efficacy ng ilan pang COVID-19 vaccines vs. Delta variant, patuloy na pinag-aaralan
02:38
DOST preparing for trials on mixing and matching COVID-19 vaccines; DOST: 4 COVID-19 vaccines approved by FDA; OCTA: NCR should remain under GCQ classification despite improving stats
10:12
Panayam kay Infectious Diseases expert President Dr. Rontgene Solante ng PCP ukol sa bagong COVID-19 variant o KP2 at KP3 variant na patuloy na binabantayan ng DOH
02:27
Express Balita: PHL, inihalal bilang chairperson ng gov't group ng int'l labor organization; Importansya ng info drive hinggil sa COVID-19 vaccines, binigyang-diin; Theta variant, 'di na maituturing na ‘variant of interest’ dahil sa pagbaba ng bilang ng n
02:29
Pagbahing at runny nose o sipon, posibleng sintomas ng COVID-19 Delta variant base sa ilang pag-aaral; Kumpletong doses ng COVID-19 vaccines, nananatiling epektibo vs. COVID-19 variants
01:49
OCTA Research Group, iginiit na mahalagang higpitan ang border control vs. COVID-19 variants; bibilhing 40-M doses ng Pfizer vaccines, makatutulong para mapabilis ang vaccine rollout
02:11
Public health England: COVID-19 vaccines ng Pfizer at AstraZeneca, epektibo vs. Indian variant; Israel, tatapusin na ang pagpapatupad ng COVID-19 restrictions matapos ideklara na matagumpay ang vaccine rollout; British Prime Minister Boris Johnson, inan
03:07
EUA ng Pfizer, kailangan munang amyendahan bago magamit sa edad 12-15 sa Pilipinas; Vaccine Expert Panel, pinag-aaralan kung epektibo ang first generation vaccines vs. B.1.617 COVID-19 variant